Dr. Harry D Harper MD Hematologist

Dr. Harry Harper is a hematologist in Hackensack, New Jersey. He is affiliated with multiple hospitals in the area, including Hackensack University Medical Center and Holy Name Medical Center. He received his medical degree from Baylor College of Medicine and has been in practice for 37 years. Dr. Harper accepts several types of health insurance, listed below. He is one of 12 doctors at Hackensack University Medical Center and one of 11 at Holy Name Medical Center who specialize in Hematology.

Are you Dr. Harry Harper? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: General Hematology

Hospital Affiliation

Hackensack University Medical Center
Ranked #35 in Cancer

Holy Name Medical Center

Education & Medical Training

New York Presbyterian Hospital, Cornell Campus
Residency, Internal Medicine, 1977 - 1980

Memorial Sloan-Kettering Cancer Center
Fellowship, Hematology, 1980 - 1983

Baylor College of Medicine
Class of 1977

Certifications & Licensure

American Board of Internal Medicine
Certified in Gastroenterology

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Transplant Hepatology

AZ State Medical License
Active through 2014

Publications & Presentations

A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non-Small Cell Lung Cancer.
Socinski, M. A.,Goldman, J.,El-Hariry, I.,Koczywas, M.,Vukovic, V.,Horn, L.,Paschold, E.,Salgia, R.,West, H.,Sequist, L. V.,Bonomi, P.,Brahmer, J.,Chen, L. C.,Sandler, A.,Belani, C. P.,Webb, T.,Harper, H.,Huberman, M.,Ramalingam, S.,Wong, K. K.,Teofilovici, F.,Guo, W.,Shapiro, G. I.

A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ???70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer.
Stinchcombe, T.E., Peterman, A.H., Lee, C.B., Moore, D.T., Beaumont, J.L., Bradford, D.S., Bakri, K., Taylor, M., Crane, J.M., Schwartz, G., Hensing, T.A., McElroy, E., Niell, H.B., Harper, H.D., Pal, S., Socinski, M.A.

The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer.
Stinchcombe, T.E., Harper, H.D., Hensing, T.A., Moore, D.T., Crane, J.M., Atkins, J.N., Willard, E.M., Detterbeck, F.C., Socinski, M.A.

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem PPO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Cofinity PPO
  • First Choice
  • First Health PPO
  • Great West PPO
  • HIP of New York - Select PPO
  • Horizon BCBS Direct Access
  • Horizon BCBS HMO
  • Horizon BCBS POS
  • Horizon BCBS PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • Premera BCBS Heritage & Heritage Plus 1
  • Providence Health System Personal Option
  • QualCare HMO
  • QualCare PPO
  • Rocky Mountain Group/Indiv - HMO/Private Pay
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.